Axon Enterprise, Inc $AXON Shares Sold by Acadian Asset Management LLC

Market Beat
2025.09.14 08:56
portai
I'm PortAI, I can summarize articles.

Acadian Asset Management LLC reduced its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 25.6% in Q1, now holding 34,197 shares valued at $17.98 million. Other hedge funds adjusted their positions, with TCTC Holdings increasing its stake by 75%. Axon shares opened at $751.11, with a market cap of $58.96 billion. The company reported $2.12 EPS, exceeding estimates, and a revenue of $668.54 million, up 32.6% year-over-year. Analysts maintain a consensus rating of "Moderate Buy" with an average target price of $837.69.

Acadian Asset Management LLC decreased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 25.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,197 shares of the biotechnology company's stock after selling 11,764 shares during the quarter. Acadian Asset Management LLC's holdings in Axon Enterprise were worth $17,975,000 at the end of the most recent reporting period.

  • Why Axon's 16% Surge Signals a New Era in Public Safety Tech

A number of other hedge funds have also made changes to their positions in AXON. TCTC Holdings LLC raised its holdings in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after acquiring an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $30,000. Bartlett & CO. Wealth Management LLC raised its holdings in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares during the last quarter. Banque Transatlantique SA acquired a new position in shares of Axon Enterprise during the first quarter valued at approximately $31,000. Finally, Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise during the first quarter valued at approximately $32,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Get Axon Enterprise alerts:

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $751.11 on Friday. Axon Enterprise, Inc has a one year low of $364.60 and a one year high of $885.91. The company has a market cap of $58.96 billion, a price-to-earnings ratio of 185.46, a PEG ratio of 27.44 and a beta of 1.40. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The business's 50 day moving average price is $761.89 and its 200 day moving average price is $684.67.

  • MarketBeat Week in Review – 06/02 - 06/06

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on AXON shares. Wolfe Research started coverage on Axon Enterprise in a report on Monday, July 7th. They set an "outperform" rating for the company. UBS Group reissued a "neutral" rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 target price for the company in a report on Tuesday, August 5th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. Finally, Bank of America lifted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $837.69.

  • AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition

Check Out Our Latest Stock Report on Axon Enterprise

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of the firm's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $723.50, for a total transaction of $54,262.50. Following the completion of the sale, the chief accounting officer owned 15,080 shares of the company's stock, valued at $10,910,380. This trade represents a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 15,919 shares of the firm's stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president directly owned 238,379 shares of the company's stock, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,790 shares of company stock valued at $34,304,947 over the last 90 days. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

  • Five stocks we like better than Axon Enterprise
  • How to Use the MarketBeat Stock Screener
  • High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
  • Short Selling - The Pros and Cons
  • Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
  • Airline Stocks - Top Airline Stocks to Buy Now
  • Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here